Product

KN035

2 clinical trials

2 indications

Indication

Indication

Biliary Tract Neoplasms

Clinical trial

Study of KN035 as Monotherapy in Patients With Advanced Mismatched Repair Deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors

Status: Recruiting, Estimated PCD: 2024-06-30

Clinical trial

Gemcitabine and Oxaliplatin With or Without KN035 for Biliary Tract Cancer: a Randomised, Open-label, Parallel-group, Multicenter Phase III Study

Status: Recruiting, Estimated PCD: 2024-07-15